Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shexiang Tongxin Dropping Pills in Coronary Slow Flow Phenomenon
ChiCTR-IPR-16008950Phase 4Recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Slow Coronary Flow (SCF) and coronary arteriosclerosis comparing Shexiang Tongxin dropping pills with Placebo (2 arms). Primary endpoint: Corrected TIMI frame count (CTFC). Started Aug 2016; status: recruiting.
02
Drugs
Shexiang Tongxin Dropping Pills
03
Conditions
Slow Coronary Flow (SCF)coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-IPR-16008950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008950.